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1. Introduction
  Oral squamous cell carcinoma (OSCC) is one of the most 
common malignant tumors of the oral and maxillofacial, 
surgery combined with radiotherapy and chemotherapy is 
still its main treatment[1]. Early detection of malignancy has 
a positive significance for the prognosis of patients, some 
studies showed that as an oral mucosa chronic non-specific 
inflammation, oral lichen planus (OLP) has a cancerous 
potential. Now we detect the expression of cyclooxygenase 
(COX)-2, MMP-7 mRNA and protein in the normal oral 
mucosa (NOM), OLP and OSCC by immunohistochemical 
SP method and RT-PCR, and to explore their role in the 
occurrence and development of the OSCC.
2. Materials and methods
2.1. Materials
   All specimens were selected from patients who received 
dentistry treatment in our hospital between 2009 and 2011 
and then confirmed by pathological analysis. There were 
Objective: To observe cyclooxygenase (COX)-2 expression in normal oral mucosa (NOM), oral 
lichen planus (OLP) and oral squamous cell carcinoma (OSCC) and explore its significance 
in the incidence of oral cancer. Methods: The immunohistochemical method and RT-PCR 
method were applied to detect the expression of COX-2 and MMP-7 in 10 cases with NOM, 33 
cases of with OLP and 38 cases with OSCC. Results:  The expression of COX-2 mRNA in OSCC 
tissues (68.4%, 26/38) was significantly higher than in the OLP (24.2%, 8/33) and NOM (0.0%, 
0/10) (P<0.01). The expression of MMP-7 mRNA in OSCC tissues (65.8%, 25/38) was significantly 
higher than in the OLP (30.3%, 10/33) and NOM (0.0%, 0/10) (P<0.01). The expression of MMP-7 
in OLP was significantly higher than in the NOM (P<0.05). There was no significant expression 
of COX-2 protein in NOM, and the positive rate was 42.4% (14/33) and 89.5% (34/38) in OLP and 
OSCC group, respectively. The COX-2 expression in cancer tissues was significantly higher than 
in NOM and OLP (P<0.05). The MMP-7 protein expression in cancer tissues (84.2%, 32/38) was 
significantly higher than in NOM (10.0%, 1/10) and in OLP (42.4%, 14/33), and the  positive rate in 
OLP was significantly higher than in NOM (P< 0.01). The COX-2 expression was associated with 
clinical stage (P<0.05), the MMP-7 expression was associated with clinical stage and lymph node 
metastasis (P<0.05). The expressions of COX-2 and MMP-7 mRNA were positively correlated 
with OSCC. Conclusions: The abnormal expressions of COX-2 and MMP-7 are closely related to 
the biological behavior of OSCC, the MMP-7 may be induced by COX-2, and further lead to the 
invasion and metastasis of OSCC.
Tie-Jun Li et al./Asian Pacific Journal of Tropical Medicine (2013)640-643 641
33 cases with OLP (18 males and 15 females, age from 20-
63 years old), 38 cases with OSCC (21 males and 17 females, 
age from 25-72 years old), which included 16 cases without 
lymph node metastasis and 22 cases with lymph node 
metastasis. According to 5th edition of oral histopathological 
squamous cell carcinoma diagnostic criteria, there were 6 
cases with class 栺 squamous cell carcinoma, 14 cases with 
class 栻 squamous cell carcinoma, 18 cases with class 栿 
squamous cell carcinoma, 8 cases with well-differentiation, 
12 cases with moderately differentiation,18 cases with poorly 
differentiation. And there were 10 cases in normal control 
group. Samples were obtained from oral cleft lip and palate 
plastic surgery.
 
2.2. Reagents
  COX-2 and MMP-7 were both rabbit anti-human 
polyclonal antibody, SP immunohistochemistry kit and DAB 
color kit were purchased from Wuhan Boster Biological 
Engineering Co., Ltd. COX-2 (304 bp) primer sequences 
was as follows: upstream: 5’-TTC AAA TGA GAT TGT GGG 
AAA ATT GCT-3’, downstream: 5’ - GAT CAT CTC TGC CTG 
AFT ATC TT-3’; MMP-7 (418 bp) primer sequences was as 
follows: upstream: 5’-ATG TTA AAC TCC GCG TCA TA-3’, 
downstream: 5’-CAG CAT ACA GGA AGT TAA TCC-3’; 
Internal reference sequences was GADPH (298 bp) upstream: 
5’-GCG-GGC TCT CCA GAA CAT CAT-3’, downstream: 
5’-CCA GCC CCA GCG TCA AAG GTG-3’. They were all 
synthesized by Shanghai Sangon Biological Engineering Co.
2.3. Experimental methods
  All specimens were divided into two groups after surgical 
resection, specimens for RT-PCR were immediately 
placed in EP tube treated by diethylprocarbonate 
(diethyl pyrocarbonate, DEPC), then prepared in low 
temperature refrigerator at -80 曟. All specimens used 
for immunohistochemistry were fixed in 10% formalinfand 
paraffin-embedded, and were measured by COX-2 and 
MMP-7 immunohistochemical staining.
  RT-PCR was operated as follows: total RNA were extracted 
from tissues by TRIzol (Invitrogen Company), cDNA was 
synthesized by reverse transcription according to the 
instructions. The cDNA synthesized by reverse transcription 
was as a template for PCR amplification, and GADPH was 
as an internal reference. COX-2 reaction conditions were 
as follows: after 95 曟 for 5 min, 95 曟 for 30 s濚62 曟 for 
30 s濚72 曟 for 30 s, 35 cycles; 72 曟 for 7 min. MMP-7 
reaction conditions were as follows: after 95 曟 for 5 min, 
95 曟 for 30 s濚53 曟 for 30 s濚72 曟 for 30 s, 35 cycles; 72 曟 
for 7 min. The amplified products were performed by 1.5% 
cleavage agarose gel eletrophoresis and EB staining. The 
immunohistochemistry was operated as follows: matured 
by immunohistochemical SP method and coloured by DAB. 
All specimens were under high temperature and high 
pressure to repair antigen, and staining in accordance with 
the reagent instructions. The positive section was used as a 
positive control, PBS instead of primary antibody was used 
as a negative control.
2.4. RT-PCR
  Positive bands were compared with Marker. Positive bands 
at 304 bp, 418 bp and 298 bp, respectively were regarded as 
positive expression of COX-2, MMP-7 and GADPH mRNA. If 
there was no positive strip band at the corresponding area, 
the result was negative.
  
2.5. Immunohistochemical staining criteria
  The semi-quantitative method to used to determine the 
results. Ten typical high power fields (暳 400) were selected 
in each slice, at least 1 000 cells were counted, and then it 
was calculated by the percentage of positive cells. COX-2, 
MMP-7 protein cytoplasm and/or nuclei in yellow-brown 
staining were considered as positive cells. Positive degree of 
tumor cells was as follows: 10% -25% were (+), 26%-50% were 
(+ +), more than 51%  were (+ + +); Slice positive cells rate≥ 
10% were regarded as positive, <10% as negative (-).
2.6. Statistical analysis
   All of the data were analyzed by t test and 氈
2 test. Fisher’s 
exact test and Spearman rank correlation analysis was 
used to analyze the correlation, P<0.05 was considered as 
statistical significance.
3. Results
3.1. COX-2, MMP-7 mRNA levels
  The positive expression rate of COX-2 mRNA in NOM, 
OLP and OSCC were 0% (0/10), 24.2% (8/33) and 68.4% (26/38), 
respectively. The expression of COX-2 in OSCC tissues 
was significantly higher than in OLP and NOM (P<0.01). 
The expression of COX-2 in OLP was slightly higher than 
in NOM (P>0.05). The positive expression rate of MMP-7 
mRNA in NOM, OLP and OSCC were 0% (0/10), 30.3% (10/33) 
and 65.8% (25/38), respectively, the expression of MMP-7 in 
OSCC tissues was significantly higher than in OLP and NOM 
(P<0.01), the expression of MMP-7 in OLP was significantly 
higher than in NOM (P<0.05).
3.2. COX-2, MMP-7 protein expression
  Immunohistochemical results showed that COX-2 has no 
significant expression in NOM, and the positive rate was 
42.4% (14/33) and 89.5% (34/38) in OLP and OSCC group, 
respectively. The COX-2 expression in cancer tissues was 
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significantly higher than in NOM and OLP (P<0.05). There 
was no significant difference in the positive expression 
between OLP and NOM. Positive particles of COX-2 protein 
was brown, mainly distributed in the cytoplasm and cell 
membrane. The positive expression rates of MMP-7 were 
10.0% (1/10) in NOM, 42.4% (14/33) in OLP, 84.2% (32/38) in 
OSCC, respectively. MMP-7 expression in cancer tissues 
was significantly higher than in NOM and OLP, and the 
expression in OLP was significantly higher than in NOM 
(P<0.01). The positive granules of MMP-7 were brow, and 
mainly distributed in the cytoplasm (Table 1).
Table 1
Expressions of COX-2 and MMP-7 protein in NOM, OLP and OSCC (n).
Groups COX-2 MMP-7
- + ++ +++ - + ++ +++
NOM 10 0   0   0 10   0   0 0
OLP 19 4   5   5 19 10   3 1
OSCC   4 6 12 16   6 14 11 7
3.3. Relationship of COX-2 and MMP-7 expressions with 
clinical pathological features
  Out of 38 cases with OSCC, aging from 25 to 72 years, 
13 cases were older than 60 years old, and 25 cases were 
less than 60 years old. In the 曒 60-year old group, 8 
cases had the expression of COX-2 mRNA and MMP-7 
mRNA, respectively. In the <60-year old group, 18 and 
17 cases had the expression of COX-2 mRNA and MMP-
7mRNA, respectively. There were 21 males and 17 females 
in OSCC group. A total of 15 male cases and 16 male cases 
had the expression of COX-2 mRNA and MMP-7 mRNA, 
respectively; while 11 female cases and 9 female cases 
had the expression of COX-2 mRNA and MMP-7 mRNA, 
respectively. 
  There were 8 well-differentiated cases, 12 moderately 
differentiated cases, 18 poorly differentiated cases in the 
OSCC group. There were 4 cases, 9 cases and 13 cases 
respectively of COX-2 mRNA expression in the well 
differentiated group,moderately differentiated group and 
the poorly differentiated group. While there were 5 cases, 8 
cases and 12 cases respectively of MMP-7mRNA expression 
in the well differentiated group,moderately differentiated 
group and the poorly differentiated group.
  The statistical analysis showed COX-2 and MMP-7 
expressions were not related with the age, gender, lymph 
node metastasis and pathological type (P>0.05). A total of 
15 cases with lymph node metastasis and 11 cases without 
lymph node metastasis had COX-2 mRNA expression 
(P>0.05); While 18 cases with lymph node metastasis and 
7 cases without lymph node metastasis had  MMP-7mRNA 
expression (P<0.05). A total of 17 cases in 栺+ 栻 stage group 
and 9 cases in 栿 group had COX-2 mRNA expression 
(P<0.05); while there were 9 cases in 栺+ 栻 stage group and 
16 cases in 栿 group had MMP-7mRNA expression (P<0.05); 
COX-2 expressions were related to the clinical stage (P 
<0.05), MMP-7 expression were related to the clinical stage 
and lymph node metastasis (P<0.05), others showed no 
correlation with clinical factors.
3.4.Correlation of COX-2 and MMP-7 expression with 
OSCC
 A total of  26 OSCC cases showed positive COX-2 mRNA 
expression, 25 cases showed positive MMP-7 mRNA 
expression, and 18 cases showed positive COX-2 and 
MMP-7 mRNA expression. Spearman rank correlation 
analysis showed COX-2 and MMP-7 mRNA expression 
showed a positive correlation with OSCC (r=0.548, P<0.05).
4. Discussion
  Oral lichen planus is an inflammatory disease of the skin 
and mucous membranes. There are a variety of clinical 
manifestations, but the specific etiology and pathogenesis 
is not clear. It is considered to be a pre-cancerous or 
precancerous state[2]. Tumor progression and metastasis is 
usually from normal tissue to precancerous lesions, and then 
the cancer formed. The principles of treatment for cancer 
are early detection, diagnosis and treatment[3]. With the 
development of molecular biology, immunology and other 
inspection techniques, it is possible to detect the presence 
of tumor markers in patient’s body fluids to assist early 
detection of cancer[4].
  Arachidonic acid (AA) metabolites are closely related 
tumor. As AA metabolism rate-limiting enzyme, COX 
plays an important role as the valve in tumorigenesis. 
There are only COX-1 and COX-2 of the COX gene. Many 
studies have shown that COX-1 as a housekeeping gene 
has a stable expression in the tissues, while COX-2 has 
almost no expression in normal epithelial tissues, but 
was highly expressed in the hyperplastic tissue, and 
more highly expressed in gastrointestinal cancer, lung 
cancer, breast cancer, liver cancer, pancreatic cancer 
and other diseases[5,6]. Some studies suggest that COX-2 
overexpression in precancerous lesions prior to the 
expression of biomarkers of apoptosis and angiogenesis, 
and involved in tumorigenesis by promoting the cell 
proliferation and inhibiting the apoptosis[7,8]. In this study, 
the mRNA and tissue protein analysis showed no expression 
of COX-2 in NOM, which is higher in OLP than in NOM, but 
not significant. The expression was significantly increased 
in OSCC, which is consistent with the relevant research. 
Associated with clinical features, we found that COX-2 
expression is higher in phase 栺 than in phase 栻 and phase 
栿, which indicating that there was obviously expression of 
COX-2 in early tumorigenesis and is closely related with the 
tumorigenesis.
  Extracellular matrix and basement membrane are stable 
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tissue cells involuntary transfer organizational structure,of 
which the matrix metalloproteinases (MMPs) genes as the 
important gene for the degradation of the extracellular matrix 
and basement membrane is extensively studied, and its 
expression was significantly increased in a variety of tumors 
,and can promote tumor growth through the activation of 
tumor tissue growth factor and inhibit the apoptosis of tumor 
cells[9-12]. The MMPs have more than 20 members, and 
MMP-7 has a strong degradation type 桇 collagen. It is also 
the only epithelial-specific product of MMPs family, which 
is related with apoptosis[13-17].
  In this study, the mRNA and tissue protein analysis 
showed no expression of MMP-7 in NOM, which is higher in 
OLP than in NOM, but not significant. The expression was 
significantly increased in OSCC. Associated with clinical 
features, we found that MMP-7 expression is higher in phase 
栿 than in phase 栺 and phase 栻, and higher in groups 
with lymph node metastasis than groups without lymph 
node metastasis, which indicating that there was obviously 
expression of MMP-7 in the process of tumor development 
and is closely related with the tumorigenesis, and indicates 
a poor prognosis. COX-2 and MMP-7 mRNA’s expression 
was positively correlated with oral squamous cell carcinoma, 
and it showed there is a correlation between the expression 
of these two genes. This study suggests that oral lichen 
planus has epithelial hyperplasia, once the proliferation of 
epithelial cells surpass the normal limits, it will change into 
abnormal differentiation cells, and cancer will become final 
results. That confirmed the malignant potential of oral lichen 
planus once again, the application and testing of COX-2 
and MMP-7 in oral precancerous lesions may provide 
clinical preventive information to blocking further malignant 
transformation of epithelial cells in the precancerous stage.
In the correlative studies of oral cancer and the expression 
of COX-2 and MMP-7, we presume that COX-2 and MMP-7 
can act on the occurrence and development process of 
oral cancer, COX-2 and MMP-7 can be used as molecular 
markers to predict oral cancer and precancerous lesions in 
clinical application.
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